Zylberberg H, Rimaniol A C, Pol S, Masson A, De Groote D, Berthelot P, Bach J F, Bréchot C, Zavala F
Unité d'Hépatologie, Hôpital Necker, Paris, France.
J Hepatol. 1999 Feb;30(2):185-91. doi: 10.1016/s0168-8278(99)80060-9.
BACKGROUND/AIMS: Tumor necrosis factor-alpha (TNF) is a mediator of inflammation and cellular immune response. Soluble TNF receptors (sTNFR) sTNF-R55 and sTNF-R75, which compete with cellular receptors for the binding of TNF, have been detected at high levels in infectious diseases including human immunodeficiency virus and HBV infection. In order to investigate the activation of the TNF system in HCV infection, we have analyzed the balance between TNF and sTNF-R in 60 HCV-infected subjects according to their clinical, biological, virological and histological characteristics.
Serum TNF, sTNF-R55 and sTNF-R75 levels were determined by ELISA before any therapy and were compared to a control group of 60 healthy subjects and a group of 34 HBV-infected patients.
Mean TNF levels were 50.5+/-4.5 pg/ml in HCV patients, and undetectable (<5 pg/ml) in the control subjects. sTNF-R55 and sTNF-R75 levels were significantly higher in HCV-infected patients than in the controls: 2.88+/-0.14 ng/ml vs. 1.30+/-0.05, (p = 0.0001), and 9.54+/-0.58 ng/ml vs. 4.19+/-016, (p = 0.0001), respectively. sTNF-R55 and TNF-alpha levels in HCV patients were not significantly different from levels in HBV patients. sTNF-R75 levels were slightly lower than in HBV patients (9.54+/-0.58 vs. 11.4+/-0.79 ng/ml, p = 0.03). In contrast to other infectious diseases, there was no correlation between levels of sTNF-R and TNF. sTNF-R75 but not TNF levels were correlated with aminotransferases levels (p = 0.0001 and p = 0.0015 for aspartate and alanine aminotransferase, respectively), while sTNF-R55 levels were significantly correlated only with aspartate aminotransferase levels (p = 0.003). sTNF-R75 levels were significantly correlated with the Metavir activity index (p = 0.01), and sTNF-R55 and sTNF-R75 levels were significantly higher in patients with vs. without cirrhosis (3.22+/-0.21 vs. 2.54+/-0.17 ng/ml (p<0.02) and 11.6+/-0.86 vs. 7.5+/-0.53 ng/ml (p<0.001), respectively). sTNF-R55, sTNF-R75 and TNF levels were not correlated with viral load, genotype or response to interferon therapy.
Levels of soluble TNF receptors, and particularly sTNF-R75, are significantly correlated with the severity of the disease but not with virological parameters such as quantitative viremia and genotype. High TNF-R production could thus suggest that HCV-related liver disease involves immunological mechanisms, including activation of the TNF system.
背景/目的:肿瘤坏死因子-α(TNF)是炎症和细胞免疫反应的介质。可溶性TNF受体(sTNFR)sTNF-R55和sTNF-R75可与细胞受体竞争结合TNF,在包括人类免疫缺陷病毒和HBV感染在内的传染病中已检测到其高水平表达。为了研究丙型肝炎病毒(HCV)感染中TNF系统的激活情况,我们根据60例HCV感染患者的临床、生物学、病毒学和组织学特征,分析了TNF与sTNF-R之间的平衡。
在任何治疗前,通过酶联免疫吸附测定(ELISA)法测定血清TNF、sTNF-R55和sTNF-R75水平,并与60例健康受试者的对照组和34例HBV感染患者的组进行比较。
HCV患者的平均TNF水平为50.5±4.5 pg/ml,而对照组受试者中未检测到(<5 pg/ml)。HCV感染患者的sTNF-R55和sTNF-R75水平显著高于对照组:分别为2.88±0.14 ng/ml对1.30±0.05(p = 0.0001),以及9.54±0.58 ng/ml对4.19±0.16(p = 0.0001)。HCV患者的sTNF-R55和TNF-α水平与HBV患者的水平无显著差异。sTNF-R75水平略低于HBV患者(9.54±0.58对11.4±0.79 ng/ml,p = 0.03)。与其他传染病不同,sTNF-R水平与TNF水平之间无相关性。sTNF-R75而非TNF水平与转氨酶水平相关(天冬氨酸转氨酶和丙氨酸转氨酶的p值分别为0.0001和0.0015),而sTNF-R55水平仅与天冬氨酸转氨酶水平显著相关(p = 0.003)。sTNF-R75水平与梅塔维(Metavir)活动指数显著相关(p = 0.01),有肝硬化与无肝硬化患者的sTNF-R55和sTNF-R75水平显著更高(分别为3.22±0.21对2.54±0.17 ng/ml(p<0.02)和11.6±0.86对7.5±0.53 ng/ml(p<0.001))。sTNF-R55、sTNF-R75和TNF水平与病毒载量、基因型或干扰素治疗反应无关。
可溶性TNF受体水平,尤其是sTNF-R75,与疾病严重程度显著相关,但与诸如定量病毒血症和基因型等病毒学参数无关。因此,高TNF-R产生可能表明HCV相关肝病涉及免疫机制,包括TNF系统的激活。